UV Clinical A/S: Financial statements 2021
CVR: 38401572
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
UV Clinical A/S (CVR 38401572) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 33,464 and a net result of DKK 2,248,332 compared with DKK -1,149,248 the year before. Equity in the 2021 report amounted to DKK 123,871. The solvency ratio was 77.5%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 33,464
- Profit/Loss
- DKK 2,248,332
- Equity
- DKK 123,871
- Total Assets
- DKK 159,793
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 33K | 2.2M | 124K | 1 |
| 2020 | - | -411K | -1.1M | -2.1M | 1 |
| 2019 | - | -577K | -1.4M | -975K | 1 |
| 2018 | - | 4K | -799K | -584K | 1 |
| 2017 | - | -376K | -1.1M | 215K | 1 |
Official annual report
Find more companies like UV Clinical A/S
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
As of December 22, 2021, Carsten Viftrup Andersen has joined the board of directors of UV Clinical A/S.
As of November 22, 2021, Claus Frisenberg Pedersen has joined the board of directors of UV Clinical A/S.
As of September 6, 2021, PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab has been appointed auditor of UV Clinical A/S.
As of September 6, 2021, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of UV Clinical A/S.
As of September 6, 2021, Helge Holm-Larsen has joined the board of directors of UV Clinical A/S.
As of August 2, 2021, Rolf Henrik Sprunk-Jansen is registered as director of UV Clinical A/S.
As of August 2, 2021, Jimmy Bak has stepped down as director of UV Clinical A/S.
As of July 12, 2021, Helge Holm-Larsen has left the board of directors of UV Clinical A/S.
As of July 9, 2021, Rolf Henrik Sprunk-Jansen has joined the board of directors of UV Clinical A/S.
As of July 9, 2021, Jan Friis Schack has left the board of directors of UV Clinical A/S.
About UV Clinical A/S
UV Clinical A/S is a Danish company of the type Aktieselskab based in Hellerup, founded in 2017. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The company was previously named UV Clinical ApS. The management consists of Rolf Henrik Sprunk-Jansen. The board consists of Helge Holm-Larsen (chair), Emilio de la Guardia Gascuñana and Rolf Henrik Sprunk-Jansen. The company is owned by Ulstrup Invest ApS, Canajo Invest ApS and Holafa ApS. The company has 3 employees (2026). In 2025, the company reported a gross profit of DKK 1,274,253 and a net result of DKK -1,282,165 compared with DKK -1,895,100 the year before. Equity in the 2025 report amounted to DKK 22,796,335.
